Literature DB >> 5339425

A clinical trial of thiocarlide (4-4' diisoamyloxythiocarbanilide).

B Urbancik.   

Abstract

Mesh：

Substances：

Year:  1966        PMID： 5339425     DOI： 10.1016/s0041-3879(66)80007-7

Source DB:  PubMed          Journal:  Tubercle        ISSN： 0041-3879


× No keyword cloud information.
  6 in total

1.  Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis.

Authors:  B Phetsuksiri; A R Baulard; A M Cooper; D E Minnikin; J D Douglas; G S Besra; P J Brennan
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  [The resistance of Mycobacterium tuberculosis to ethionamide, thiosemicarbazone and isoxyl and their relations to each other].

Authors:  H Eule; E Werner
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1967

3.  Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis.

Authors:  Benjawan Phetsuksiri; Mary Jackson; Hataichanok Scherman; Michael McNeil; Gurdyal S Besra; Alain R Baulard; Richard A Slayden; Andrea E DeBarber; Clifton E Barry; Mark S Baird; Dean C Crick; Patrick J Brennan
Journal:  J Biol Chem       Date:  2003-10-14       Impact factor: 5.157

4.  [Cooperative controlled trial of thiocarlide (DATC), PAS and bedrest alone in short-term single-drug treatment in retreated cavitary pulmonary tuberculosis].

Authors: 
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1969

5.  Isoxyl activation is required for bacteriostatic activity against Mycobacterium tuberculosis.

Authors:  Jana Korduláková; Yves L Janin; Avraham Liav; Nathalie Barilone; Tiago Dos Vultos; Jean Rauzier; Patrick J Brennan; Brigitte Gicquel; Mary Jackson
Journal:  Antimicrob Agents Chemother       Date:  2007-09-04       Impact factor: 5.191

6.  EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets.

Authors:  Lynn G Dover; Anuradha Alahari; Paul Gratraud; Jessica M Gomes; Veemal Bhowruth; Robert C Reynolds; Gurdyal S Besra; Laurent Kremer
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.